Trials / Unknown
UnknownNCT05536466
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
a multicentre phase IV study to collect evidence that a doravirine-based regimen can be safely and effectively administered to virologically suppressed HIV-infected patients undergoing bariatric suregery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | bariatric surgery | bariatric surgery |
Timeline
- Start date
- 2022-09-30
- Primary completion
- 2023-07-23
- Completion
- 2023-08-01
- First posted
- 2022-09-10
- Last updated
- 2022-09-10
Source: ClinicalTrials.gov record NCT05536466. Inclusion in this directory is not an endorsement.